Kelly Y. Lin

A case series of primary cutaneous coccidioidomycosis after a record-breaking rainy season

D. Cassarino, J. Shiu, A. Elsensohn, 2018, JAAD case reports.

Perioperative, functional, and oncologic outcomes of partial adrenalectomy for multiple ipsilateral pheochromocytomas.

W. Linehan, P. Pinto, W. Linehan, 2014, Journal of endourology.

EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy

S. Horvath, M. Prados, M. Mehta, 2009, Science Signaling.

The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

C. James, J. Heath, T. Cloughesy, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical The mTOR Kinase Inhibitors , CC 2141 and CC 2142 , Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

C. James, J. Heath, T. Cloughesy, 2013 .

Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.

W. Linehan, P. Pinto, G. Bratslavsky, 2012, The Journal of urology.

Abstract 645: Preclinical efficacy of AZD8055, an ATP-competitive mammalian target of rapamycin (mTOR) kinase inhibitor,in vitroin clear cell renal cell carcinoma (RCC)

W. Linehan, R. Srinivasan, S. Guichard, 2011 .

Clinical evaluation of 2-(18F) fluoro-2 deoxy-D-glucose PET/ CT in hereditary leiomyomatosis and renal cell carcinoma.

W. Linehan, R. Srinivasan, G. Bratslavsky, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1860 OUTCOMES OF PATIENTS WITH SURGICALLY TREATED BILATERAL RENAL MASSES AND A MINIMUM OF 10 YEARS OF FOLLOW-UP: THE NCI EXPERIENCE

W. Linehan, P. Pinto, G. Bratslavsky, 2011 .